Medicis Pharmaceutical Corp. (MRX) Tops Q2 EPS by 39c
Tweet
Share
E-mailGet Alerts MRX Hot Sheet
Price: $78.27 --0%
EPS Growth %: +27.1%
Financial Fact:
Basic net income (loss) per share: 0.02
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +27.1%
Financial Fact:
Basic net income (loss) per share: 0.02
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Medicis Pharmaceutical Corp. (NASDAQ: MRX) reported Q2 EPS of $1.64, $0.39 better than the analyst estimate of $1.25. Revenue for the quarter came in at $695.8 million versus the consensus estimate of $595.88 million.
For earnings history and earnings-related data on Medicis Pharmaceutical Corp. (MRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
- H.C. Wainwright Reiterates Buy Rating on Opus Genetics (IRD)
- Merck (MRK) PT Raised to $170 at Guggenheim
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
